GLPill

Orforglipron (Foundayo) Price: What It Actually Costs in 2026

By Ayush Gupta · Published July 17, 2026 · Updated July 17, 2026

Educational information, not medical advice. This guide is for general understanding of oral GLP-1 medicines. Always follow your prescriber's instructions and talk to a qualified clinician about your treatment.

If you’re searching “orforglipron price,” you probably already know Foundayo is the first daily GLP-1 pill approved for weight management — and now you want to know what it actually costs. The honest answer: it depends almost entirely on how you’re paying. Here’s what Eli Lilly has published, what shapes the number you’ll actually see, and where to check for the current price before you plan around it.

This is educational, not financial or medical advice

Nothing here is a guarantee of what you personally will pay, and it isn’t medical advice about whether Foundayo is right for you. Drug pricing changes — sometimes month to month — and your actual cost depends on your dose, insurance plan, pharmacy, and any savings programs you qualify for. Always confirm the current price with Lilly’s official site, your pharmacy, or your insurer.

What Eli Lilly has published

Per Eli Lilly’s own announcement and its LillyDirect Foundayo page, three price points show up depending on how you pay:

  • Self-pay (no insurance), through LillyDirect: starting at $149/month for the 0.8 mg starting dose, stepping up with the dose — roughly $199/month at 2.5 mg and $299/month at 5.5 mg and the higher maintenance doses.
  • Commercial insurance with the Foundayo savings card: eligible, commercially insured patients with coverage for Foundayo may pay as little as $25/month.
  • Medicare Part D: eligible patients may be able to get Foundayo for around $50/month.

These are Lilly’s own published figures as of this writing — not a universal price. Terms and conditions apply to the savings card and Medicare offer (for example, government-insured patients typically aren’t eligible for the commercial savings card), and Lilly has not published a separate standalone list price (WAC) the way some pricing databases show for other drugs. What you’ll encounter as a patient is one of the numbers above, not a separate “sticker price.”

The one thing to remember: the price is not a single number. It’s a range that depends on whether you’re self-pay, insured, or on Medicare — and it changes as you move up the dose titration.

Why the price moves with your dose

Foundayo is started low and titrated upward over months (see our Foundayo dosing guide for the full schedule). Lilly’s self-pay pricing tracks that: the 0.8 mg starting dose is priced lower than the 2.5 mg step, which is priced lower than the 5.5 mg–17.2 mg maintenance range. In practice, that means your monthly self-pay cost in month one is likely to be lower than your cost once you reach a maintenance dose several months in — worth factoring into a monthly budget rather than assuming a flat number for the whole year.

Insurance and coverage

Whether insurance covers Foundayo — and how much you’ll owe — depends on your specific plan. Some commercial plans cover GLP-1s for weight management, often requiring prior authorization; others don’t cover weight-management indications at all, or cover them with a higher copay than diabetes indications. Medicare Part D coverage for weight-management GLP-1s has also been evolving.

Because this varies so much by plan, the only reliable way to know your actual cost is to:

  1. Ask your insurer directly whether Foundayo is covered for your indication, and what your copay or coinsurance would be.
  2. Ask your pharmacy to run a test claim so you see the real out-of-pocket number before you commit.
  3. Check whether you’re eligible for Lilly’s savings card, which can significantly lower the cost for commercially insured patients.

Savings cards and self-pay programs

Manufacturer savings programs are often the biggest lever on price. Lilly’s Foundayo savings card is aimed at commercially insured patients with coverage for the drug, and its LillyDirect self-pay path is aimed at people without insurance coverage for it — these are different programs with different eligibility, so don’t assume one applies if you qualify for the other. Programs like this also tend to have terms that can change (income limits, government-insurance exclusions, refill-timing requirements for promotional pricing), so read the current terms rather than relying on a secondhand summary — including this one.

Cash pay vs. going through insurance

If you don’t have coverage for Foundayo, cash/self-pay through LillyDirect is generally going to be cheaper than paying full price at a retail pharmacy without any assistance, since it’s Lilly’s own direct-to-patient pricing. If you do have insurance, it’s worth comparing your insured copay against the self-pay price — occasionally the self-pay or savings-card price is actually lower than a high-deductible plan’s copay, especially early in the plan year.

Cost vs. injectable GLP-1s

Orforglipron is a small-molecule pill, not an injectable peptide like semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro). That distinction gets discussed a lot in coverage of the drug because small molecules are generally simpler and cheaper to manufacture and scale than injectable peptides — which is part of the reason some analysts and outlets have speculated oral GLP-1s could eventually put downward pressure on GLP-1 pricing broadly.

That’s useful context, but it’s not a promise of a specific discount. Injectable GLP-1 pricing also varies widely by self-pay program, insurance, and dose, and both drug classes are still relatively new to the market with pricing that continues to shift. If cost is a deciding factor between an oral and injectable option, compare current self-pay and insured prices for each directly rather than assuming pills are automatically cheaper. Our pill vs. injection comparison covers the other differences beyond price.

Where to check the current price

Because pricing changes, treat every number in this article as a snapshot rather than a guarantee:

  • Lilly’s official Foundayo/LillyDirect pages for current self-pay pricing by dose and savings-card eligibility.
  • Your pharmacy for your actual out-of-pocket cost after any insurance and coupons.
  • Your insurer or Medicare Part D plan for coverage status, prior authorization requirements, and your specific copay.

If you’re also weighing side effects as part of the cost-benefit picture, our orforglipron side effects guide covers what to expect as you titrate up through the doses discussed above.

Frequently asked questions

How much does orforglipron (Foundayo) cost per month?

It depends heavily on how you're paying. Per Eli Lilly's own pricing, self-pay through LillyDirect starts at $149/month for the 0.8 mg starting dose and rises with the dose (roughly $199/month at 2.5 mg, $299/month at 5.5 mg and above). Eligible commercially insured patients may pay as little as $25/month with the Foundayo savings card, and eligible Medicare Part D patients may pay around $50/month. These figures can change, so confirm the current price before you budget around it.

Is there a list price for Foundayo?

Eli Lilly's own press materials and LillyDirect page publish self-pay and insured pricing, but as of this writing they don't publicize a standalone list price (WAC) the way some drug-pricing databases do for other medications. What you'll actually encounter as a patient is the self-pay, insured, or Medicare price — not a separate list price.

Why does the price change by dose?

Foundayo is titrated up over months, from 0.8 mg to as high as 17.2 mg. Lilly's self-pay pricing increases at higher doses — starting around $149/month at 0.8 mg and topping out around $299/month at 5.5 mg and above. So your monthly cost early in treatment is typically lower than your cost once you reach a maintenance dose.

Is orforglipron cheaper than injectable GLP-1s like Zepbound or Wegovy?

Being a small-molecule pill rather than an injectable peptide is often discussed as a reason oral GLP-1s could be cheaper to manufacture and scale over time, which may support more competitive pricing. But list and self-pay prices for GLP-1 medications shift frequently and vary by manufacturer program, insurance, and pharmacy — so don't assume a specific discount. Compare current self-pay and insured prices directly rather than relying on a general 'pills are cheaper' assumption.

Does insurance cover Foundayo?

Coverage varies by plan. Some commercial plans cover it (often with prior authorization for weight management), and Lilly's savings card can lower the out-of-pocket cost for eligible commercially insured patients. Medicare Part D coverage has also been evolving. Because coverage and formulary status change, check directly with your insurer and pharmacy for your specific plan.

Where can I check the current, exact price?

Prices change, so treat any number — including the ones in this article — as a snapshot. Check Eli Lilly's official LillyDirect/Foundayo pages for current self-pay and savings-card pricing, ask your pharmacy for your out-of-pocket cost after insurance, and check with your insurer or Medicare Part D plan directly for your coverage details.

Sources

  1. FDA approves Lilly's Foundayo (orforglipron) — official press release with pricing (PR Newswire / Eli Lilly)
  2. Foundayo (orforglipron) — official LillyDirect medicine page, self-pay pricing by dose
  3. FOUNDAYO (orforglipron) tablets — FDA-approved label (DailyMed)
  4. FDA Approves First New Molecular Entity Under National Priority Voucher Program (FDA)

Tracking an oral GLP-1?

GLPill logs your daily pill, times the 30-minute wait, and charts your progress — privately.

Get the app →

← All guides